Glycocalyx-Edited Mesenchymal Stem/Stromal Cell Therapy in Advanced Osteoporosis

Researchers conducted a first-in-human clinical trial involving a single intravenous infusion of glycocalyx-edited autologous bone marrow-derived MSCs in ten women with advanced-stage osteoporosis